Filing Details
- Accession Number:
- 0001140361-11-011215
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-22 17:12:22
- Reporting Period:
- 2011-02-17
- Filing Date:
- 2011-02-22
- Accepted Time:
- 2011-02-22 17:12:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
880643 | Genta Inc De | GNTA | Biological Products, (No Disgnostic Substances) (2836) | 330326866 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1100843 | Jr P Raymond Warrell | C/O Genta Incorporated 200 Connell Drive Berkeley Heights NJ 07922 | Chairman & Chief Exec Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-02-17 | 820,000 | $0.01 | 1,082,803,801 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-02-18 | 15,600 | $0.25 | 21,640,472 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2011-02-22 | 580,000 | $0.16 | 21,094,588 | No | 4 | X | Direct | |
Common Stock | Disposition | 2011-02-22 | 150,000 | $0.25 | 20,944,588 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | X | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | March 2010 Warrant | Disposition | 2011-02-22 | 1,125,884 | $0.00 | 580,000 | $0.16 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
9,738,707 | 2010-03-09 | 2013-03-09 | No | 4 | X | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 152,695 | Indirect | By spouse |
Footnotes
- Includes 780,000 shares of common stock held in joint account with Dr. Warrell's spouse, Dr. Itri, 5,981,681 shares of common stock potentially issuable upon the vesting of currently outstanding restricted stock units, 529,519,984 shares of common stock issuable upon the conversion of Senior Convertible Promissory Notes due September 4, 2011, as amended (the Notes), 3,032,500 shares of common stock issuable upon the conversion of Notes held by Dr. Warrell's IRA, 486,935,389 shares of common stock issuable upon the exercise of March 2010 Warrants, 56,250,980 shares of common stock issuable upon the exercise of December 2010 Warrants and 303,267 shares of common stock issuable upon the exercise of December 2010 Warrants held by Dr. Warrell's IRA.
- Adjusted for a 1:50 reverse stock split implemented February 18, 2011.Includes 119,632 shares of common stock potentially issuable upon the vesting of currently outstanding restricted stock units,10,590,399 shares of common stock issuable upon the conversion of Notes, 60,650 shares of common stock issuable upon the conversion of Notes held by Dr. Warrell's IRA, 9,738,707 shares of common stock issuable upon the exercise of March 2010 Warrants, 1,125,019 shares of common stock issuable upon the exercise of December 2010 Warrants and 6,065 shares of common stock issuable upon the exercise of December 2010 Warrants held by Dr. Warrell's IRA.
- Includes 52,622 shares of common stock potentially issuable upon the vesting of currently outstanding restricted stock units held by Dr. Itri, 90,975 shares of common stock issuable upon the conversion of Notes held by Dr. Itri and 9,098 shares of common stock issuable upon the exercise of December 2010 Warrants.